Parenteral Plant Sterols and Intestinal Failure–associated Liver Disease in Neonates
- 1 June 2012
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 54 (6), 803-811
- https://doi.org/10.1097/mpg.0b013e3182474118
Abstract
We prospectively evaluated incidence of prolonged (>28 days) parenteral nutrition (PN), associated complications, and significance of parenteral plant sterols (PS) in neonatal intestinal failure-associated liver disease (IFALD) compared with children. We recruited 28 neonates (mean age 50 days, range 28-126) and 11 children (6.9 y, 2.1-16.6) in all of Finland. Patients underwent repeated measurements of serum cholesterol, noncholesterol sterols, including PS, cholestanol and cholesterol precursors, and liver biochemistry during and 1 month after discontinuation of PN. Healthy matched neonates (n=10) and children (n=22) served as controls. IFALD occurred more frequently among neonates (63%) than children (27%; P<0.05). Ratios of serum PS, including stigmasterol, sitosterol, avenasterol, and campesterol, and total PS were increased among neonates compared with healthy controls and children on PN by 2- to 22- and 2- to 5-fold (P<0.005), respectively. Neonates with IFALD had significantly higher ratios of serum PS and cholestanol compared with neonates without IFALD (P<0.05). Total duration of PN associated with serum cholestanol, stigmasterol, avenasterol, alanine aminotransferase, and aspartate aminotransferase (r=0.472-0.636, P<0.05). Cholestanol and individual serum PS, excluding campesterol, reflected direct bilirubin (r=0.529-0.688, P<0.05). IFALD persisted after discontinuation of PN in 25% of neonates with 4.2- and 2.2-times higher ratios of serum stigmasterol and cholestanol compared with neonates without IFALD (P<0.05). Frequent occurrence of IFALD among neonates on PN displays an association to duration of PN and markedly increased serum PS, especially stigmasterol, in comparison to healthy neonates and children on PN. Striking accumulation of parenteral PS may contribute to IFALD among neonates.Keywords
This publication has 44 references indexed in Scilit:
- Surrogate markers of cholesterol metabolism in children with native liver after successful portoenterostomy for biliary atresiaJournal of Pediatric Surgery, 2010
- Parenteral Fish Oil Improves Outcomes in Patients With Parenteral Nutrition-Associated Liver InjuryAnnals of Surgery, 2009
- Pediatric Short Bowel SyndromeAnnals of Surgery, 2005
- The Enzymes, Regulation, and Genetics of Bile Acid SynthesisAnnual Review of Biochemistry, 2003
- Chronic liver disease in children on long‐term parenteral nutritionJournal of Gastroenterology and Hepatology, 1996
- Total parenteral nutrition impairs bile flow and alters bile composition in newborn pigletDigestive Diseases and Sciences, 1996
- The metabolism of cholestanol in primary biliary cirrhosisJournal of Hepatology, 1996
- Parenteral nutrition—Related cholestasis in postsurgical neonates: Multivariate analysis of rick factorsJournal of Pediatric Surgery, 1996
- Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver diseaseCell, 1993
- High cholestanol and low campesterol-to-sitosterol ratio in serum of patients with primary biliary cirrhosis before liver transplantationJournal of Hepatology, 1991